Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group (Q43528801)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group |
scientific article |
Statements
1 reference
Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group (English)
1 reference
Ursula Vehling-Kaiser
1 reference
Ludwig Fischer von Weikersthal
1 reference
Nicolas Moosmann
1 reference
Martina Stauch
1 reference
Holger G Hass
1 reference
Herrmann Dietzfelbinger
1 reference
Daniel Oruzio
1 reference
Stefan Klein
1 reference
Klaus Zellmann
1 reference
Thomas Decker
1 reference
Mathias Schulze
1 reference
Wolfgang Abenhardt
1 reference
Gerhard Puchtler
1 reference
Herbert Kappauf
1 reference
Johann Mittermüller
1 reference
Christopher Haberl
1 reference
Andreas Schalhorn
1 reference
Andreas Jung
1 reference
Sebastian Stintzing
1 reference
Volker Heinemann
1 reference
7 February 2011
1 reference
1 reference
29
1 reference
8
1 reference
1050-1058
1 reference
Identifiers
1 reference
1 reference